• OmicSoft Studio: RNA-seq and expression data analysis

    Virtual - Americas - EST , United States

    In this 90-minute training, attendees will learn how to use basic expression analysis (example RNA-seq) functionalities in QIAGEN OmicSoft Studio and how that integrates with OncoLand, DiseaseLand and Single Cell Land. This webinar will focus on expression data analysis using QIAGEN OmicSoft Studio’s powerful analysis and visualization capabilities to explore your ‘omics data: Accepted data formats […]

  • IPA deep dive: miRNA investigation using QIAGEN Ingenuity Pathway Analysis (IPA)

    Virtual - Americas - EST , United States

    In this 90-minute training session, you will learn how to identify target mRNAs for your miRNAs of interest and associate them with pathways, diseases, biological functions, tissues and cell types. Topics that will be covered include: How to analyze miRNA-seq datasets alone or both miRNA and corresponding mRNA datasets together How to use QIAGEN IPA […]

  • Public single-cell expression data made easy with QIAGEN IPA

    Virtual - Americas - EST , United States

    Many QIAGEN Ingenuity Pathway Analysis (IPA) users have expressed interest in taking advantage of public single-cell expression data. Such data is readily available and easily accessible in IPA. We are hosting a 1hr training focused on some common use cases related to this topic. You'll learn to: Easily locate single-cell studies, samples or cell types […]

  • Achieving Good Manufacturing Production (GxP) compliance with NGS (EMEA)

    Virtual - EMEA - CET

    New guidelines for the viral safety evaluation of biotechnology products from the International Council for Harmonisation (ICH) recommend replacing multiple in vivo and in vitro assays with next-generation sequencing (NGS) to maintain good manufacturing practices. If that sounds like a lot, we’ve got you covered. In this webinar, we’ll explore how you can easily apply […]

  • Achieving Good Manufacturing Production (GxP) compliance with NGS (Americas)

    Virtual - Americas - EST , United States

    New guidelines for the viral safety evaluation of biotechnology products from the International Council for Harmonisation (ICH) recommend replacing multiple in vivo and in vitro assays with next-generation sequencing (NGS) to maintain good manufacturing practices. If that sounds like a lot, we’ve got you covered. In this webinar, we’ll explore how you can easily apply […]

  • QIAGEN IPA new user training

    Virtual - Americas - EST , United States

    Are you new to QIAGEN Ingenuity Pathway Analysis (IPA) or interested in expanding your skill set? Join us as we learn more on large dataset analysis and knowledge base queries using QIAGEN IPA. You’ll learn to: Upload multiple dataset types (e.g., RNA-seq, proteomics, metabolomics) and perform interactive core/pathway analysis in IPA Learn how to interpret […]

  • Custom patient cohorts: Making discoveries with curated genomics data

    Virtual - Americas - EST , United States

    Are you interested in exploring how you can evaluate phenotypic differences between custom cohorts? You can learn more about drug response, survival, co-expressing biomarkers, mutations and more based on gene expression. In this webinar, you'll learn how to investigate patient cohorts using high-quality curated genomic repositories like the QIAGEN OmicSoft Lands database. You'll be able […]

  • Metatranscriptome analysis, annotation and pathways investigations using CLC Genomics Workbench

    Virtual - Americas - EST , United States

    Using CLC Genomics Workbench, we will go through a pipeline for analyzing metatranscriptome NGS data from microbial communities and perform pathways interpretation on it. Import "raw" NGS sequencing data and prepare the samples for analysis Find relevant annotated genomes with a curated reference database while removing ribosomal RNA with the SILVA database (database of rRNAs) […]

  • Expanding neoantigen discovery with COSMIC

    Virtual - Americas - EST , United States

    Neoantigens are among the newest promising targets for cancer treatment. Unlike tumor-associated antigens, neoantigens are produced only by tumor cells. These unique molecular markers are highly visible to the immune system, making them ideal for personalized immunotherapies. They may also be able to predict both tumor survival prognosis and immune checkpoint blockade responses. Neoantigens are […]

  • OmicSoft Diseaseland Training

    Virtual - Americas - EST , United States

    Per feedback of scientists interested in taking advantage of non-oncological diseases (inflammatory, infectious, metabolic and more) as well as normal tissues (example toxicology/target safety assessment) omics, we are hosting this training focused OmicSoft Diseaseland. OmicSoft Diseaseland is a repository which contain high quality curated ‘omic data (RNA-seq, scRNA-seq, microarray and more) from diverse data-sources (example […]

  • Third Annual Clinical Hereditary Disease Diagnostics Summit "Exome experts: Improving the interpretation and integration of exome testing in routine clinical care"

    Virtual - Americas - EST , United States

    Industry leaders discuss how to improve the speed, precision and cost-effectiveness of clinical exome testing for newborn screening and rare and undiagnosed diseases Clinical exome testing is revolutionizing the diagnosis of rare and inherited diseases. Its ability to quickly pinpoint the genetic causes of complex conditions has made it a critical component of personalized medicine, […]